Rajika Perera

Company: Poseidon LLC

Job title: Chief Executive Officer

Seminars:

Protein Therapeutics Simplified: Next Generation Protein Modality as T-cell Engagers 9:00 am

Our technology is designed to rapidly generate bispecific therapeutics with various novel and existing moieties such as nanobodies, scFvs, and non-antibody domains in a “LEGO”-like manner to generate TCEs The TCEs have very high safety profiles compared to conventional biologics and low pro-inflammatory cytokines In vivo efficacy has been demonstrated in NSCLC mouse modelsRead more

day: Day Two